Dual-Algorithm Integration Framework Reveals Qing-Wei-Zhi-Tong’s Dual Mechanisms in Chronic Gastritis Article Swipe
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.3390/ph18111743
Background: Chronic gastritis (CG) involves gastric mucosal imbalance, with H. pylori (>90% cases), acid-pepsin imbalance, and bile reflux as druggable mechanisms. FDA-approved drugs show limited efficacy against antibiotic-resistant strains and fail to target undruggable pathways (e.g., inflammation, autoimmune atrophy). Traditional Chinese Medicine (TCM), particularly Qing-Wei-Zhi-Tong micro-pills (QWZT), offers multi-target advantages, though its mechanisms remain poorly understood. Methods: The dual-algorithm integration framework predicts QWZT’s pharmacological effects to treat gastritis. For druggable processes (pathways targeted by existing drugs), the structure–target–pathway similarity algorithm quantifies QWZT similar activities to FDA drugs, validated by gastrointestinal smooth muscle experiments. For undruggable processes (novel biological mechanisms not addressed by current therapies), the multi-target perturbation algorithm predicts QWZT’s unique capacity to undruggable processes and is validated via LPS-induced inflammation in RAW264.7 and GES-1 cells. Results: Structure–target–pathway similarity algorithm identified QWZT compounds sharing prokinetic mechanisms with FDA drugs, validated by dopamine-induced relaxations and acetylcholine-induced contractions in gastrointestinal smooth muscle. Multi-target perturbation algorithm quantified QWZT’s superior disruption of undruggable immune/inflammation networks, confirmed by restored cell viability in LPS-injured GES-1 cells and significantly reduced the expression of NO, IL-6, and TNF-α in RAW264.7 cells via key compounds (paeoniflorin and berberine). Conclusions: QWZT may exert its regulatory effects on gastrointestinal smooth muscle by mediating muscarinic and dopamine receptor D2 (DRD2), and reduce the expression of NO, IL-6, and TNF-α to achieve anti-inflammatory effects, thereby effectively treating CG. The integration strategy that integrates algorithms and experiments to reveal the common and distinct mechanisms of QWZT compared to FDA-approved drugs, offering a novel approach for studying Traditional Chinese Medicine mechanisms.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.3390/ph18111743
- https://www.mdpi.com/1424-8247/18/11/1743/pdf?version=1763376865
- OA Status
- gold
- References
- 72
- OpenAlex ID
- https://openalex.org/W7105836023
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W7105836023Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.3390/ph18111743Digital Object Identifier
- Title
-
Dual-Algorithm Integration Framework Reveals Qing-Wei-Zhi-Tong’s Dual Mechanisms in Chronic GastritisWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-11-17Full publication date if available
- Authors
-
Zhijie Shu, Ying Huang, Yujie Xi, Bo Zhang, Rui Cai, He Xu, Feifei Guo, Zhijie Shu, Ying Huang, Yujie Xi, Bo Zhang, Rui Cai, He Xu, Feifei GuoList of authors in order
- Landing page
-
https://doi.org/10.3390/ph18111743Publisher landing page
- PDF URL
-
https://www.mdpi.com/1424-8247/18/11/1743/pdf?version=1763376865Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.mdpi.com/1424-8247/18/11/1743/pdf?version=1763376865Direct OA link when available
- Concepts
-
Druggability, Medicine, Chronic gastritis, Bioinformatics, Computational biology, Pharmacology, Precision medicine, Gastritis, Helicobacter pylori, Traditional Chinese medicine, Systems biology, Drug discovery, Biology, Mechanism (biology), Personalized medicine, InflammationTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
72Number of works referenced by this work
Full payload
| id | https://openalex.org/W7105836023 |
|---|---|
| doi | https://doi.org/10.3390/ph18111743 |
| ids.doi | https://doi.org/10.3390/ph18111743 |
| ids.openalex | https://openalex.org/W7105836023 |
| fwci | 0.0 |
| type | article |
| title | Dual-Algorithm Integration Framework Reveals Qing-Wei-Zhi-Tong’s Dual Mechanisms in Chronic Gastritis |
| biblio.issue | 11 |
| biblio.volume | 18 |
| biblio.last_page | 1743 |
| biblio.first_page | 1743 |
| topics[0].id | https://openalex.org/T12059 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.3223179578781128 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2736 |
| topics[0].subfield.display_name | Pharmacology |
| topics[0].display_name | Berberine and alkaloids research |
| topics[1].id | https://openalex.org/T10211 |
| topics[1].field.id | https://openalex.org/fields/17 |
| topics[1].field.display_name | Computer Science |
| topics[1].score | 0.0806550681591034 |
| topics[1].domain.id | https://openalex.org/domains/3 |
| topics[1].domain.display_name | Physical Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1703 |
| topics[1].subfield.display_name | Computational Theory and Mathematics |
| topics[1].display_name | Computational Drug Discovery Methods |
| topics[2].id | https://openalex.org/T11709 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.06710502505302429 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2707 |
| topics[2].subfield.display_name | Complementary and alternative medicine |
| topics[2].display_name | Traditional Chinese Medicine Analysis |
| is_xpac | False |
| apc_list.value | 2000 |
| apc_list.currency | CHF |
| apc_list.value_usd | 2165 |
| apc_paid.value | 2000 |
| apc_paid.currency | CHF |
| apc_paid.value_usd | 2165 |
| concepts[0].id | https://openalex.org/C10679952 |
| concepts[0].level | 3 |
| concepts[0].score | 0.9089255332946777 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q5308937 |
| concepts[0].display_name | Druggability |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.5247020125389099 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C2780561475 |
| concepts[2].level | 4 |
| concepts[2].score | 0.42984119057655334 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q183130 |
| concepts[2].display_name | Chronic gastritis |
| concepts[3].id | https://openalex.org/C60644358 |
| concepts[3].level | 1 |
| concepts[3].score | 0.4235561788082123 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q128570 |
| concepts[3].display_name | Bioinformatics |
| concepts[4].id | https://openalex.org/C70721500 |
| concepts[4].level | 1 |
| concepts[4].score | 0.40054887533187866 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q177005 |
| concepts[4].display_name | Computational biology |
| concepts[5].id | https://openalex.org/C98274493 |
| concepts[5].level | 1 |
| concepts[5].score | 0.3780227303504944 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[5].display_name | Pharmacology |
| concepts[6].id | https://openalex.org/C163763905 |
| concepts[6].level | 2 |
| concepts[6].score | 0.3745687007904053 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q17075943 |
| concepts[6].display_name | Precision medicine |
| concepts[7].id | https://openalex.org/C2778677798 |
| concepts[7].level | 3 |
| concepts[7].score | 0.35954704880714417 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q183130 |
| concepts[7].display_name | Gastritis |
| concepts[8].id | https://openalex.org/C2776409635 |
| concepts[8].level | 2 |
| concepts[8].score | 0.34975308179855347 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q180556 |
| concepts[8].display_name | Helicobacter pylori |
| concepts[9].id | https://openalex.org/C188947578 |
| concepts[9].level | 3 |
| concepts[9].score | 0.3148221969604492 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q200253 |
| concepts[9].display_name | Traditional Chinese medicine |
| concepts[10].id | https://openalex.org/C152662350 |
| concepts[10].level | 2 |
| concepts[10].score | 0.29305338859558105 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q815297 |
| concepts[10].display_name | Systems biology |
| concepts[11].id | https://openalex.org/C74187038 |
| concepts[11].level | 2 |
| concepts[11].score | 0.27986547350883484 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q1418791 |
| concepts[11].display_name | Drug discovery |
| concepts[12].id | https://openalex.org/C86803240 |
| concepts[12].level | 0 |
| concepts[12].score | 0.26454776525497437 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[12].display_name | Biology |
| concepts[13].id | https://openalex.org/C89611455 |
| concepts[13].level | 2 |
| concepts[13].score | 0.2642839550971985 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q6804646 |
| concepts[13].display_name | Mechanism (biology) |
| concepts[14].id | https://openalex.org/C32220436 |
| concepts[14].level | 2 |
| concepts[14].score | 0.2565494775772095 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q2072214 |
| concepts[14].display_name | Personalized medicine |
| concepts[15].id | https://openalex.org/C2776914184 |
| concepts[15].level | 2 |
| concepts[15].score | 0.2560312747955322 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q101991 |
| concepts[15].display_name | Inflammation |
| keywords[0].id | https://openalex.org/keywords/druggability |
| keywords[0].score | 0.9089255332946777 |
| keywords[0].display_name | Druggability |
| keywords[1].id | https://openalex.org/keywords/chronic-gastritis |
| keywords[1].score | 0.42984119057655334 |
| keywords[1].display_name | Chronic gastritis |
| keywords[2].id | https://openalex.org/keywords/precision-medicine |
| keywords[2].score | 0.3745687007904053 |
| keywords[2].display_name | Precision medicine |
| keywords[3].id | https://openalex.org/keywords/gastritis |
| keywords[3].score | 0.35954704880714417 |
| keywords[3].display_name | Gastritis |
| keywords[4].id | https://openalex.org/keywords/helicobacter-pylori |
| keywords[4].score | 0.34975308179855347 |
| keywords[4].display_name | Helicobacter pylori |
| keywords[5].id | https://openalex.org/keywords/traditional-chinese-medicine |
| keywords[5].score | 0.3148221969604492 |
| keywords[5].display_name | Traditional Chinese medicine |
| language | en |
| locations[0].id | doi:10.3390/ph18111743 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S16322639 |
| locations[0].source.issn | 1424-8247 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1424-8247 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Pharmaceuticals |
| locations[0].source.host_organization | https://openalex.org/P4310310987 |
| locations[0].source.host_organization_name | Multidisciplinary Digital Publishing Institute |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310310987 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.mdpi.com/1424-8247/18/11/1743/pdf?version=1763376865 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Pharmaceuticals |
| locations[0].landing_page_url | https://doi.org/10.3390/ph18111743 |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A2770393430 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-2739-5455 |
| authorships[0].author.display_name | Zhijie Shu |
| authorships[0].countries | CN |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I200296433 |
| authorships[0].affiliations[0].raw_affiliation_string | State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China |
| authorships[0].institutions[0].id | https://openalex.org/I200296433 |
| authorships[0].institutions[0].ror | https://ror.org/https://ror.org/02drdmm93 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[0].institutions[0].country_code | CN |
| authorships[0].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Zhijie Shu |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China |
| authorships[1].author.id | https://openalex.org/A2096183289 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-5184-0032 |
| authorships[1].author.display_name | Ying Huang |
| authorships[1].countries | CN |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I200296433 |
| authorships[1].affiliations[0].raw_affiliation_string | Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China |
| authorships[1].institutions[0].id | https://openalex.org/I200296433 |
| authorships[1].institutions[0].ror | https://ror.org/https://ror.org/02drdmm93 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[1].institutions[0].country_code | CN |
| authorships[1].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Ying Huang |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China |
| authorships[2].author.id | https://openalex.org/A3134822117 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-0269-868X |
| authorships[2].author.display_name | Yujie Xi |
| authorships[2].countries | CN |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I200296433 |
| authorships[2].affiliations[0].raw_affiliation_string | Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China |
| authorships[2].institutions[0].id | https://openalex.org/I200296433 |
| authorships[2].institutions[0].ror | https://ror.org/https://ror.org/02drdmm93 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[2].institutions[0].country_code | CN |
| authorships[2].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Yujie Xi |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China |
| authorships[3].author.id | https://openalex.org/A2097431157 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-5081-7607 |
| authorships[3].author.display_name | Bo Zhang |
| authorships[3].countries | CN |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210141683 |
| authorships[3].affiliations[0].raw_affiliation_string | Jiangxi Province Key Laboratory of Traditional Chinese Medicine Pharmacology, Institute of Traditional Chinese Medicine Health Industry, China Academy of Chinese Medical Sciences, Nanchang 330115, China |
| authorships[3].institutions[0].id | https://openalex.org/I4210141683 |
| authorships[3].institutions[0].ror | https://ror.org/https://ror.org/042pgcv68 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210141683 |
| authorships[3].institutions[0].country_code | CN |
| authorships[3].institutions[0].display_name | China Academy of Chinese Medical Sciences |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Bo Zhang |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Jiangxi Province Key Laboratory of Traditional Chinese Medicine Pharmacology, Institute of Traditional Chinese Medicine Health Industry, China Academy of Chinese Medical Sciences, Nanchang 330115, China |
| authorships[4].author.id | https://openalex.org/A1977198338 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-6163-8823 |
| authorships[4].author.display_name | Rui Cai |
| authorships[4].countries | CN |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I200296433 |
| authorships[4].affiliations[0].raw_affiliation_string | State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China |
| authorships[4].institutions[0].id | https://openalex.org/I200296433 |
| authorships[4].institutions[0].ror | https://ror.org/https://ror.org/02drdmm93 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[4].institutions[0].country_code | CN |
| authorships[4].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Rui Cai |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China |
| authorships[5].author.id | https://openalex.org/A2100252417 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-5494-9236 |
| authorships[5].author.display_name | He Xu |
| authorships[5].countries | CN |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I200296433 |
| authorships[5].affiliations[0].raw_affiliation_string | State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China |
| authorships[5].institutions[0].id | https://openalex.org/I200296433 |
| authorships[5].institutions[0].ror | https://ror.org/https://ror.org/02drdmm93 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[5].institutions[0].country_code | CN |
| authorships[5].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | He Xu |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China |
| authorships[6].author.id | https://openalex.org/A2109052317 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-1390-5584 |
| authorships[6].author.display_name | Feifei Guo |
| authorships[6].countries | CN |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I200296433 |
| authorships[6].affiliations[0].raw_affiliation_string | State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China |
| authorships[6].institutions[0].id | https://openalex.org/I200296433 |
| authorships[6].institutions[0].ror | https://ror.org/https://ror.org/02drdmm93 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[6].institutions[0].country_code | CN |
| authorships[6].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Feifei Guo |
| authorships[6].is_corresponding | True |
| authorships[6].raw_affiliation_strings | State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China |
| authorships[7].author.id | https://openalex.org/A2770393430 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-2739-5455 |
| authorships[7].author.display_name | Zhijie Shu |
| authorships[7].countries | CN |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I200296433 |
| authorships[7].affiliations[0].raw_affiliation_string | State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China |
| authorships[7].institutions[0].id | https://openalex.org/I200296433 |
| authorships[7].institutions[0].ror | https://ror.org/https://ror.org/02drdmm93 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[7].institutions[0].country_code | CN |
| authorships[7].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Zhijie Shu |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China |
| authorships[8].author.id | https://openalex.org/A2096183289 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-5184-0032 |
| authorships[8].author.display_name | Ying Huang |
| authorships[8].countries | CN |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I200296433 |
| authorships[8].affiliations[0].raw_affiliation_string | Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China |
| authorships[8].institutions[0].id | https://openalex.org/I200296433 |
| authorships[8].institutions[0].ror | https://ror.org/https://ror.org/02drdmm93 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[8].institutions[0].country_code | CN |
| authorships[8].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Ying Huang |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China |
| authorships[9].author.id | https://openalex.org/A3134822117 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-0269-868X |
| authorships[9].author.display_name | Yujie Xi |
| authorships[9].countries | CN |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I200296433 |
| authorships[9].affiliations[0].raw_affiliation_string | Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China |
| authorships[9].institutions[0].id | https://openalex.org/I200296433 |
| authorships[9].institutions[0].ror | https://ror.org/https://ror.org/02drdmm93 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[9].institutions[0].country_code | CN |
| authorships[9].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Yujie Xi |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China |
| authorships[10].author.id | https://openalex.org/A2097431157 |
| authorships[10].author.orcid | https://orcid.org/0000-0001-5081-7607 |
| authorships[10].author.display_name | Bo Zhang |
| authorships[10].countries | CN |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210141683 |
| authorships[10].affiliations[0].raw_affiliation_string | Jiangxi Province Key Laboratory of Traditional Chinese Medicine Pharmacology, Institute of Traditional Chinese Medicine Health Industry, China Academy of Chinese Medical Sciences, Nanchang 330115, China |
| authorships[10].institutions[0].id | https://openalex.org/I4210141683 |
| authorships[10].institutions[0].ror | https://ror.org/https://ror.org/042pgcv68 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210141683 |
| authorships[10].institutions[0].country_code | CN |
| authorships[10].institutions[0].display_name | China Academy of Chinese Medical Sciences |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Bo Zhang |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Jiangxi Province Key Laboratory of Traditional Chinese Medicine Pharmacology, Institute of Traditional Chinese Medicine Health Industry, China Academy of Chinese Medical Sciences, Nanchang 330115, China |
| authorships[11].author.id | https://openalex.org/A1977198338 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-6163-8823 |
| authorships[11].author.display_name | Rui Cai |
| authorships[11].countries | CN |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I200296433 |
| authorships[11].affiliations[0].raw_affiliation_string | State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China |
| authorships[11].institutions[0].id | https://openalex.org/I200296433 |
| authorships[11].institutions[0].ror | https://ror.org/https://ror.org/02drdmm93 |
| authorships[11].institutions[0].type | education |
| authorships[11].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[11].institutions[0].country_code | CN |
| authorships[11].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Rui Cai |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China |
| authorships[12].author.id | https://openalex.org/A2100252417 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-5494-9236 |
| authorships[12].author.display_name | He Xu |
| authorships[12].countries | CN |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I200296433 |
| authorships[12].affiliations[0].raw_affiliation_string | State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China |
| authorships[12].institutions[0].id | https://openalex.org/I200296433 |
| authorships[12].institutions[0].ror | https://ror.org/https://ror.org/02drdmm93 |
| authorships[12].institutions[0].type | education |
| authorships[12].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[12].institutions[0].country_code | CN |
| authorships[12].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | He Xu |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China |
| authorships[13].author.id | https://openalex.org/A2109052317 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-1390-5584 |
| authorships[13].author.display_name | Feifei Guo |
| authorships[13].countries | CN |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I200296433 |
| authorships[13].affiliations[0].raw_affiliation_string | State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China |
| authorships[13].institutions[0].id | https://openalex.org/I200296433 |
| authorships[13].institutions[0].ror | https://ror.org/https://ror.org/02drdmm93 |
| authorships[13].institutions[0].type | education |
| authorships[13].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[13].institutions[0].country_code | CN |
| authorships[13].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[13].author_position | last |
| authorships[13].raw_author_name | Feifei Guo |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.mdpi.com/1424-8247/18/11/1743/pdf?version=1763376865 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-11-17T00:00:00 |
| display_name | Dual-Algorithm Integration Framework Reveals Qing-Wei-Zhi-Tong’s Dual Mechanisms in Chronic Gastritis |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-18T23:42:31.664661 |
| primary_topic.id | https://openalex.org/T12059 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.3223179578781128 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2736 |
| primary_topic.subfield.display_name | Pharmacology |
| primary_topic.display_name | Berberine and alkaloids research |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.3390/ph18111743 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S16322639 |
| best_oa_location.source.issn | 1424-8247 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1424-8247 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Pharmaceuticals |
| best_oa_location.source.host_organization | https://openalex.org/P4310310987 |
| best_oa_location.source.host_organization_name | Multidisciplinary Digital Publishing Institute |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310310987 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.mdpi.com/1424-8247/18/11/1743/pdf?version=1763376865 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Pharmaceuticals |
| best_oa_location.landing_page_url | https://doi.org/10.3390/ph18111743 |
| primary_location.id | doi:10.3390/ph18111743 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S16322639 |
| primary_location.source.issn | 1424-8247 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1424-8247 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Pharmaceuticals |
| primary_location.source.host_organization | https://openalex.org/P4310310987 |
| primary_location.source.host_organization_name | Multidisciplinary Digital Publishing Institute |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310310987 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.mdpi.com/1424-8247/18/11/1743/pdf?version=1763376865 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Pharmaceuticals |
| primary_location.landing_page_url | https://doi.org/10.3390/ph18111743 |
| publication_date | 2025-11-17 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W2790840865, https://openalex.org/W2101970576, https://openalex.org/W2183787411, https://openalex.org/W1966133025, https://openalex.org/W4366598306, https://openalex.org/W2570938003, https://openalex.org/W2336356383, https://openalex.org/W4311917785, https://openalex.org/W4387643698, https://openalex.org/W2134967712, https://openalex.org/W1999852902, https://openalex.org/W4411383303, https://openalex.org/W2736900167, https://openalex.org/W4406083741, https://openalex.org/W4385814147, https://openalex.org/W3036403204, https://openalex.org/W2063635801, https://openalex.org/W2032578590, https://openalex.org/W2902905490, https://openalex.org/W2324986020, https://openalex.org/W4390711247, https://openalex.org/W4237095724, https://openalex.org/W3212922804, https://openalex.org/W2912444530, https://openalex.org/W3043241116, https://openalex.org/W4401894158, https://openalex.org/W4413758000, https://openalex.org/W4399732078, https://openalex.org/W3086732443, https://openalex.org/W2396191616, https://openalex.org/W4289844287, https://openalex.org/W1804453693, https://openalex.org/W2279201083, https://openalex.org/W2979076520, https://openalex.org/W2612467560, https://openalex.org/W2297764176, https://openalex.org/W2045270356, https://openalex.org/W2928665623, https://openalex.org/W2103017472, https://openalex.org/W4294216483, https://openalex.org/W2169678694, https://openalex.org/W103340358, https://openalex.org/W3135719965, https://openalex.org/W4282913408, https://openalex.org/W2537679995, https://openalex.org/W2537623931, https://openalex.org/W4220920364, https://openalex.org/W2408104232, https://openalex.org/W4411873297, https://openalex.org/W2156729062, https://openalex.org/W4400399689, https://openalex.org/W4403480220, https://openalex.org/W4406107099, https://openalex.org/W4318834075, https://openalex.org/W2969781818, https://openalex.org/W4388514075, https://openalex.org/W4200181095, https://openalex.org/W2030147910, https://openalex.org/W4292848034, https://openalex.org/W3092351524, https://openalex.org/W4391164523, https://openalex.org/W4408772915, https://openalex.org/W223345270, https://openalex.org/W4401362468, https://openalex.org/W4408655694, https://openalex.org/W2963974522, https://openalex.org/W3195190752, https://openalex.org/W3151115053, https://openalex.org/W4409653263, https://openalex.org/W1991829452, https://openalex.org/W1997213260, https://openalex.org/W3201447985 |
| referenced_works_count | 72 |
| abstract_inverted_index.a | 247 |
| abstract_inverted_index.D2 | 206 |
| abstract_inverted_index.H. | 9 |
| abstract_inverted_index.as | 18 |
| abstract_inverted_index.by | 73, 88, 101, 140, 162, 200 |
| abstract_inverted_index.in | 121, 146, 166, 180 |
| abstract_inverted_index.is | 116 |
| abstract_inverted_index.of | 157, 175, 212, 240 |
| abstract_inverted_index.on | 196 |
| abstract_inverted_index.to | 31, 65, 84, 112, 217, 233, 243 |
| abstract_inverted_index.CG. | 224 |
| abstract_inverted_index.FDA | 85, 137 |
| abstract_inverted_index.For | 68, 93 |
| abstract_inverted_index.NO, | 176, 213 |
| abstract_inverted_index.The | 57, 225 |
| abstract_inverted_index.and | 15, 29, 115, 123, 143, 170, 178, 187, 203, 208, 215, 231, 237 |
| abstract_inverted_index.for | 250 |
| abstract_inverted_index.its | 51, 193 |
| abstract_inverted_index.key | 184 |
| abstract_inverted_index.may | 191 |
| abstract_inverted_index.not | 99 |
| abstract_inverted_index.the | 76, 104, 173, 210, 235 |
| abstract_inverted_index.via | 118, 183 |
| abstract_inverted_index.(CG) | 3 |
| abstract_inverted_index.QWZT | 81, 131, 190, 241 |
| abstract_inverted_index.bile | 16 |
| abstract_inverted_index.cell | 164 |
| abstract_inverted_index.fail | 30 |
| abstract_inverted_index.show | 23 |
| abstract_inverted_index.that | 228 |
| abstract_inverted_index.with | 8, 136 |
| abstract_inverted_index.GES-1 | 124, 168 |
| abstract_inverted_index.IL-6, | 177, 214 |
| abstract_inverted_index.cells | 169, 182 |
| abstract_inverted_index.drugs | 22 |
| abstract_inverted_index.exert | 192 |
| abstract_inverted_index.novel | 248 |
| abstract_inverted_index.treat | 66 |
| abstract_inverted_index.(TCM), | 42 |
| abstract_inverted_index.(e.g., | 35 |
| abstract_inverted_index.(novel | 96 |
| abstract_inverted_index.TNF-α | 179, 216 |
| abstract_inverted_index.cells. | 125 |
| abstract_inverted_index.common | 236 |
| abstract_inverted_index.drugs, | 86, 138, 245 |
| abstract_inverted_index.muscle | 91, 199 |
| abstract_inverted_index.offers | 47 |
| abstract_inverted_index.poorly | 54 |
| abstract_inverted_index.pylori | 10 |
| abstract_inverted_index.reduce | 209 |
| abstract_inverted_index.reflux | 17 |
| abstract_inverted_index.remain | 53 |
| abstract_inverted_index.reveal | 234 |
| abstract_inverted_index.smooth | 90, 148, 198 |
| abstract_inverted_index.target | 32 |
| abstract_inverted_index.though | 50 |
| abstract_inverted_index.unique | 110 |
| abstract_inverted_index.(DRD2), | 207 |
| abstract_inverted_index.(QWZT), | 46 |
| abstract_inverted_index.Chinese | 40, 253 |
| abstract_inverted_index.Chronic | 1 |
| abstract_inverted_index.achieve | 218 |
| abstract_inverted_index.against | 26 |
| abstract_inverted_index.cases), | 12 |
| abstract_inverted_index.current | 102 |
| abstract_inverted_index.drugs), | 75 |
| abstract_inverted_index.effects | 64, 195 |
| abstract_inverted_index.gastric | 5 |
| abstract_inverted_index.limited | 24 |
| abstract_inverted_index.mucosal | 6 |
| abstract_inverted_index.muscle. | 149 |
| abstract_inverted_index.reduced | 172 |
| abstract_inverted_index.sharing | 133 |
| abstract_inverted_index.similar | 82 |
| abstract_inverted_index.strains | 28 |
| abstract_inverted_index.thereby | 221 |
| abstract_inverted_index.(>90% | 11 |
| abstract_inverted_index.Medicine | 41, 254 |
| abstract_inverted_index.Methods: | 56 |
| abstract_inverted_index.QWZT’s | 62, 109, 154 |
| abstract_inverted_index.RAW264.7 | 122, 181 |
| abstract_inverted_index.Results: | 126 |
| abstract_inverted_index.approach | 249 |
| abstract_inverted_index.capacity | 111 |
| abstract_inverted_index.compared | 242 |
| abstract_inverted_index.distinct | 238 |
| abstract_inverted_index.dopamine | 204 |
| abstract_inverted_index.effects, | 220 |
| abstract_inverted_index.efficacy | 25 |
| abstract_inverted_index.existing | 74 |
| abstract_inverted_index.involves | 4 |
| abstract_inverted_index.offering | 246 |
| abstract_inverted_index.pathways | 34 |
| abstract_inverted_index.predicts | 61, 108 |
| abstract_inverted_index.receptor | 205 |
| abstract_inverted_index.restored | 163 |
| abstract_inverted_index.strategy | 227 |
| abstract_inverted_index.studying | 251 |
| abstract_inverted_index.superior | 155 |
| abstract_inverted_index.targeted | 72 |
| abstract_inverted_index.treating | 223 |
| abstract_inverted_index.(pathways | 71 |
| abstract_inverted_index.addressed | 100 |
| abstract_inverted_index.algorithm | 79, 107, 129, 152 |
| abstract_inverted_index.atrophy). | 38 |
| abstract_inverted_index.compounds | 132, 185 |
| abstract_inverted_index.confirmed | 161 |
| abstract_inverted_index.druggable | 19, 69 |
| abstract_inverted_index.framework | 60 |
| abstract_inverted_index.gastritis | 2 |
| abstract_inverted_index.mediating | 201 |
| abstract_inverted_index.networks, | 160 |
| abstract_inverted_index.processes | 70, 95, 114 |
| abstract_inverted_index.validated | 87, 117, 139 |
| abstract_inverted_index.viability | 165 |
| abstract_inverted_index.activities | 83 |
| abstract_inverted_index.algorithms | 230 |
| abstract_inverted_index.autoimmune | 37 |
| abstract_inverted_index.biological | 97 |
| abstract_inverted_index.disruption | 156 |
| abstract_inverted_index.expression | 174, 211 |
| abstract_inverted_index.gastritis. | 67 |
| abstract_inverted_index.identified | 130 |
| abstract_inverted_index.imbalance, | 7, 14 |
| abstract_inverted_index.integrates | 229 |
| abstract_inverted_index.mechanisms | 52, 98, 135, 239 |
| abstract_inverted_index.muscarinic | 202 |
| abstract_inverted_index.prokinetic | 134 |
| abstract_inverted_index.quantified | 153 |
| abstract_inverted_index.quantifies | 80 |
| abstract_inverted_index.regulatory | 194 |
| abstract_inverted_index.similarity | 78, 128 |
| abstract_inverted_index.Background: | 0 |
| abstract_inverted_index.LPS-induced | 119 |
| abstract_inverted_index.LPS-injured | 167 |
| abstract_inverted_index.Traditional | 39, 252 |
| abstract_inverted_index.acid-pepsin | 13 |
| abstract_inverted_index.advantages, | 49 |
| abstract_inverted_index.berberine). | 188 |
| abstract_inverted_index.effectively | 222 |
| abstract_inverted_index.experiments | 232 |
| abstract_inverted_index.integration | 59, 226 |
| abstract_inverted_index.mechanisms. | 20, 255 |
| abstract_inverted_index.micro-pills | 45 |
| abstract_inverted_index.relaxations | 142 |
| abstract_inverted_index.therapies), | 103 |
| abstract_inverted_index.understood. | 55 |
| abstract_inverted_index.undruggable | 33, 94, 113, 158 |
| abstract_inverted_index.Conclusions: | 189 |
| abstract_inverted_index.FDA-approved | 21, 244 |
| abstract_inverted_index.Multi-target | 150 |
| abstract_inverted_index.contractions | 145 |
| abstract_inverted_index.experiments. | 92 |
| abstract_inverted_index.inflammation | 120 |
| abstract_inverted_index.multi-target | 48, 105 |
| abstract_inverted_index.particularly | 43 |
| abstract_inverted_index.perturbation | 106, 151 |
| abstract_inverted_index.(paeoniflorin | 186 |
| abstract_inverted_index.inflammation, | 36 |
| abstract_inverted_index.significantly | 171 |
| abstract_inverted_index.dual-algorithm | 58 |
| abstract_inverted_index.pharmacological | 63 |
| abstract_inverted_index.dopamine-induced | 141 |
| abstract_inverted_index.gastrointestinal | 89, 147, 197 |
| abstract_inverted_index.Qing-Wei-Zhi-Tong | 44 |
| abstract_inverted_index.anti-inflammatory | 219 |
| abstract_inverted_index.immune/inflammation | 159 |
| abstract_inverted_index.antibiotic-resistant | 27 |
| abstract_inverted_index.acetylcholine-induced | 144 |
| abstract_inverted_index.Structure–target–pathway | 127 |
| abstract_inverted_index.structure–target–pathway | 77 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 14 |
| citation_normalized_percentile.value | 0.81922203 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |